Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

NutriBand (NTRB) Research & Development (2021 - 2026)

NutriBand (NTRB) has disclosed Research & Development for 6 consecutive years, with $188036.0 as the latest value for Q1 2026.

  • For Q1 2026, Research & Development fell 61.61% year-over-year to $188036.0; the TTM value through Jan 2026 reached $1.9 million, down 39.37%, while the annual FY2026 figure was $1.9 million, 39.37% down from the prior year.
  • Research & Development hit $188036.0 in Q1 2026 for NutriBand, down from $457113.0 in the prior quarter.
  • Across five years, Research & Development topped out at $974535.0 in Q2 2024 and bottomed at $117814.0 in Q2 2022.
  • Average Research & Development over 5 years is $482546.9, with a median of $457113.0 recorded in 2025.
  • Year-over-year, Research & Development soared 239.88% in 2023 and then tumbled 61.61% in 2026.
  • NutriBand's Research & Development stood at $290718.0 in 2022, then surged by 89.7% to $551503.0 in 2023, then surged by 59.7% to $880768.0 in 2024, then plummeted by 48.1% to $457113.0 in 2025, then crashed by 58.86% to $188036.0 in 2026.
  • According to Business Quant data, Research & Development over the past three periods came in at $188036.0, $457113.0, and $562554.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.